Recruiting PHASE2/PHASE3 INTERVENTIONAL 1-arm
NCT07399587
Optimizing HFrEF Patients Using BaroStim and CardioMems
Optimizing the Management of Patients With Heart Failure With Reduced Ejection Fraction Using BaroStim and CardioMems
Sponsor: Northwell Health
Conditions
Heart Failure NYHA Class III
Interventions
BaroStim
Updated 1 time since 2026 Last updated: Feb 2, 2026 Started: Jan 17, 2025 Primary completion: Dec 31, 2028 Completion: Dec 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2/PHASE3 trial investigates Heart Failure NYHA Class III and is currently actively recruiting participants. Northwell Health leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
1 version recorded Recruiting — PHASE2/PHASE3
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Northwell Health
Data source: Northwell Health
For direct contact, visit the study record on ClinicalTrials.gov .